Patents by Inventor Debra Thomas

Debra Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210038620
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: October 23, 2020
    Publication date: February 11, 2021
    Applicant: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Debra Thomas, Joseph Schaller
  • Patent number: 10813940
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: October 27, 2020
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Debra Thomas, Joseph Schaller
  • Publication number: 20180008623
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: September 18, 2017
    Publication date: January 11, 2018
    Applicant: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Debra Thomas, Joseph Schaller
  • Publication number: 20070142469
    Abstract: Disdosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the individual an amount of ?-hydroxy-?-methylbutyrate (HMB) effective to modulate or otherwise cause an increase in the ratio of type 1 to type 2 cytokines, induding an increase in the ratio of type 1 to type 2 cytokines without a corresponding increase in type 2 cytokine levels. Also disdosed are methods of using HMB to treat asthma and allergies. The methods of the present invention are based upon the discovery that HMB modulates cytokine production, most typically by increasing type 1 cytokines without a corresponding increase in type 2 cytokines.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 21, 2007
    Inventors: Debra Thomas, Pradip Mukerji